Cost-Effectiveness Evaluation of Chlorhexidine Coated vs. Standard Peripherally Inserted Central Catheters (PICCs)
Preprint
- 14 February 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Peripherally inserted central catheters (PICCs) play a crucial role in providing long-term intravenous therapy for patients requiring extended vascular access. With multiple PICC types available, understanding their cost-effectiveness is essential for healthcare decisions that balance clinical benefits with economic considerations. This study assesses the economic and clinical outcomes of chlorhexidine-coated PICCs (Type A) versus standard PICCs (Type B), aiming to guide best practices in vascular access by addressing the gap in comprehensive cost-effectiveness comparisons. Using a decision-analytic model, costs and quality-adjusted life years (QALYs) between the two types were compared. Primary data from five Chinese university-affiliated medical centers were gathered from 2020 to 2023, with a Delphi panel validating the model inputs. The analysis revealed that while Type A PICCs offer lower initial placement costs, they incur higher complication rates compared to Type B PICCs, which influences long-term cost-effectiveness. After adjusting for complication rates and QALYs, Type B PICCs emerged as more cost-effective over a one-year period, with an incremental cost-effectiveness ratio (ICER) of ¥-40,043.78 ($5,905.90, average exchange rate ¥678.03=$100) per QALY gained. Although Type B PICCs have higher initial costs, their lower complication rates make them a more valuable option for long-term vascular access, offering better overall cost-efficiency.Keywords
All Related Versions
This publication has 34 references indexed in Scilit:
- Developing Criteria for Health Economic Quality Evaluation ToolValue in Health, 2023
- Effectiveness and ost-efficacy of iuretics ome dministration via eripherally nserted entral enous atheter in atients with nd- tage eart ailureInternational Journal of Cardiology, 2022
- Central venous catheter–related infections in hematology and oncology: 2020 updated guidelines on diagnosis, management, and prevention by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)Annals of Hematology, 2020
- Cost-Effectiveness Analysis and Decision Modelling: A Tutorial for CliniciansJournal of Clinical and Experimental Hepatology, 2020
- ECG Guided Tip Positioning Technique for Peripherally Inserted Central Catheters in a teaching Hospital: Feasibility and Cost-effectiveness Analysis in a Prospective Cohort Study.European Journal of Vascular and Endovascular Surgery, 2019
- Impact of mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) on central line-associated bloodstream infections (CLABSIs) in department of hematology at single university hospital in JapanJournal of Infection and Chemotherapy, 2018
- A comparative evaluation of antimicrobial coated versus nonantimicrobial coated peripherally inserted central catheters on associated outcomes: A randomized controlled trialAmerican Journal of Infection Control, 2016
- Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adultsCochrane Database of Systematic Reviews, 2016
- Statistical Issues in Economic Evaluations2014
- Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheterAnnals of Hematology, 2004